Attenuation of insulin-stimulated insulin receptor substrate-1 serine 307 phosphorylation in insulin resistance of type 2 diabetes.
about
Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunctionRegulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinaseIdentification of the amino acids 300-600 of IRS-2 as 14-3-3 binding region with the importance of IGF-1/insulin-regulated phosphorylation of Ser-573A hierarchical whole-body modeling approach elucidates the link between in Vitro insulin signaling and in Vivo glucose homeostasis.Exercise and Glycemic Control: Focus on Redox Homeostasis and Redox-Sensitive Protein Signaling.Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetesA single mechanism can explain network-wide insulin resistance in adipocytes from obese patients with type 2 diabetes.Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.Linking mitochondrial bioenergetics to insulin resistance via redox biologyDissection of the insulin signaling pathway via quantitative phosphoproteomics.Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes.Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.Impaired tethering and fusion of GLUT4 vesicles in insulin-resistant human adipose cells.Systems-wide Experimental and Modeling Analysis of Insulin Signaling through Forkhead Box Protein O1 (FOXO1) in Human Adipocytes, Normally and in Type 2 Diabetes.Short-term overeating induces insulin resistance in fat cells in lean human subjects.Acute High-Intensity Interval Exercise-Induced Redox Signaling Is Associated with Enhanced Insulin Sensitivity in Obese Middle-Aged Men.Acupuncture Alters Expression of Insulin Signaling Related Molecules and Improves Insulin Resistance in OLETF Rats.Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.Physical inactivity, insulin resistance, and the oxidative-inflammatory loop.Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells: IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASECross-talks via mTORC2 can explain enhanced activation in response to insulin in diabetic patients.Induction of insulin resistance by the adipokines resistin, leptin, plasminogen activator inhibitor-1 and retinol binding protein 4 in human megakaryocytes.Effect of insulin levels on the phosphorylation of specific amino acid residues in IRS-1: implications for burn-induced insulin resistance.A systems study reveals concurrent activation of AMPK and mTOR by amino acids.Phosphorylation of serine 1137/1138 of mouse insulin receptor substrate (IRS) 2 regulates cAMP-dependent binding to 14-3-3 proteins and IRS2 protein degradation.Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cellsThe Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling.Progressive obesity alters ovarian insulin, phosphatidylinositol-3 kinase, and chemical metabolism signaling pathways and potentiates ovotoxicity induced by phosphoramide mustard in mice.Dose-related effects of ferric citrate supplementation on endoplasmic reticular stress responses and insulin signalling pathways in streptozotocin-nicotinamide-induced diabetes.Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907.
P2860
Q24632414-8276C2CF-3603-4E8B-9821-6BF2E2713EBFQ28272571-AD0375F4-995B-47B9-940B-F8B846D4D067Q28485906-16682E37-10EC-49C5-9C1F-F226E61B694EQ28573834-3191AEA9-17C7-4AE4-8B23-25B7F9CB896AQ30502552-73485328-565F-4CDC-8112-E8DDC24390DFQ33639120-92BD09AA-226A-4D30-86DA-58EF6F06F78FQ33959129-AEB75D1D-8CA0-436D-8A47-330B13D53CA0Q34580282-89BDE5AD-2389-427E-98B8-1212F1305796Q35221333-AD7809B3-B1F4-441B-A8EF-C9364B46D87DQ35855378-748C1B1A-3A31-431F-8198-ED6C8C3F91E1Q36497303-F2186231-73E5-4D4C-9BCF-8E2B84C3CD26Q36742249-F00C51DF-B65B-4B41-974C-198F93EB3133Q36884668-B36A5045-3287-42E1-8B8D-2842A8772231Q37110583-FC2606D7-2238-4CC6-BEB4-32858D3062EEQ37117331-B5108534-6E76-4985-8B8A-0F2D3399C2A0Q37254552-F3BE6B07-E145-46FC-B1EF-E2F2F6FBE470Q37261554-8645E250-C466-487B-BDF1-641864761223Q37322732-900B17CB-57A2-4D42-8D47-8DED195DF57AQ38123696-C69BD8A4-005C-4D87-9F34-C27FF41F538AQ38141219-C80FC20F-9EE8-4226-80E0-D9E1AC4F2900Q38265601-BEDA4FCF-F571-4FDC-B53F-DCBF314852FCQ38725775-8BF74A1F-E050-41C6-8E42-AE5865F12E82Q39366558-F4CAF251-9812-45D8-B7A6-C220CBFA4729Q39804854-C6F17374-6C03-4265-8AFB-DC25BB8BFA2CQ41889379-2B64AA45-6A7D-4315-99AF-D4117673B6EFQ42144044-415C9F4A-4515-48BA-8F2F-F90808EC6C3CQ42153597-B89F25D9-6B4A-462C-A454-184B9BA983EAQ47119946-6385B2BD-462E-4AFE-9988-D261888A707DQ47566629-1E175443-DBA3-47FC-8A65-E65FFD73C64EQ53262666-77E291EE-14FB-4DC8-AF52-38A13B3426BCQ54631286-5E200929-3CEA-4076-B390-07ECF5A675B0
P2860
Attenuation of insulin-stimulated insulin receptor substrate-1 serine 307 phosphorylation in insulin resistance of type 2 diabetes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Attenuation of insulin-stimula ...... resistance of type 2 diabetes.
@en
Attenuation of insulin-stimula ...... resistance of type 2 diabetes.
@nl
type
label
Attenuation of insulin-stimula ...... resistance of type 2 diabetes.
@en
Attenuation of insulin-stimula ...... resistance of type 2 diabetes.
@nl
prefLabel
Attenuation of insulin-stimula ...... resistance of type 2 diabetes.
@en
Attenuation of insulin-stimula ...... resistance of type 2 diabetes.
@nl
P2860
P921
P356
P1476
Attenuation of insulin-stimula ...... resistance of type 2 diabetes
@en
P2093
Anna Danielsson
P2860
P304
34389-34392
P356
10.1074/JBC.C500230200
P407
P577
2005-08-29T00:00:00Z